Online citations, reference lists, and bibliographies.

ENDOGENOUS ENDOPHTHALMITIS ASSOCIATED WITH INTRAVENOUS DRUG ABUSE

S. Patel, Ronald J Rescigno, M. Zarbin, P. Langer, Neelakshi Bhagat
Published 2014 · Biology, Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Purpose: To describe demographics, characteristics, and management of eyes with endogenous endophthalmitis (EE) in intravenous drug abusers. Methods: Retrospective chart review of patients with EE who presented to University Hospital, New Jersey Medical School between January 2005 and October 2012. Results: Thirty-four patients presented with a clinical diagnosis of EE during this time period. Eighteen patients (53%) had a history of intravenous drug abuse with at least 15 of the 18 patients reporting intravenous heroin abuse. Average age was 43 years (24–61 years), 13 were men. Three patients had bilateral involvement. Mean time from the onset of symptoms to presentation was 10 days (range, 1–42 days). Presenting vision in the affected eye ranged from 20/100 to no light perception; the majority of patients had vision of counting fingers or worse. All patients were admitted to the hospital for intravenous antimicrobials and further workup. Final best-corrected visual acuity at the last follow-up ranged from 20/20 to no light perception, with most patients having final vision of 20/400 or worse. Conclusion: We reviewed 21 eyes of 18 patients with EE and concurrent intravenous drug abuse over an 8-year period; our study shows extremely poor visual prognosis associated with EE in this setting.
This paper references
10.1007/s003470070049
[Candida endophthalmitis in drug abuse. case report.
Angelika Klein (2000)
10.5301/EJO.2009.881
Diagnostic utility of polymerase chain reaction on intraocular specimens to establish the etiology of infectious endophthalmitis.
Parameswaran Sowmya (2009)
10.1093/clinids/4.1.97
Bacillus cereus panophthalmitis: source of the organism.
D Shamsuddin (1982)
10.1007/s003470070049
Candida-Endophthalmitis bei Drogenabusus Eine Patientendemonstration
Angelika Klein (2000)
Candida endophthalmitis in drug abuse
A Klein (2000)
10.1097/IAE.0b013e3181dd6db6
ENDOGENOUS ENDOPHTHALMITIS ASSOCIATED WITH INTRAVENOUS DRUG ABUSE: Seven-Year Experience at a Tertiary Referral Center
Paul P. Connell (2010)
Report of a ten-year retrospective study
A A Okada (1994)
10.5694/j.1326-5377.1984.tb132597.x
Role of the lemon in disseminated candidiasis of heroin abusers.
H. Newton-John (1984)
10.1016/S0891-5520(02)00013-2
Ocular manifestations of injection drug use.
Rubin W. Kim (2002)
10.1128/CMR.13.4.662-685.2000
Fungal and parasitic infections of the eye.
Stephen A Klotz (2000)
10.1097/SMJ.0B013E3181581191
Endophthalmitis associated with intravenous drug use.
Kian Keyashian (2007)
10.1016/S0002-9394(14)71976-2
Fusarium endophthalmitis in an intravenous drug abuser.
Peter D. Gabriele (1996)
10.1097/IIO.0b013e3181d26dfc
Endogenous Endophthalmitis in the Developing World
J. Arevalo (2010)
10.1016/s0161-6420(13)31255-x
Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study.
Annabelle A Okada (1994)
10.1007/BF01964128
Possible role of preserved lemon juice in the epidemiology of candida endophtalmitis in heroin addicts
G. Shankland (2005)
10.1016/S0039-6257(03)00054-7
Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases.
T. Jackson (2003)
10.1001/archopht.1979.01020010248012
Bacillus cereus endogenous panophthalmitis.
E. Fernandez Bouza (1979)



This paper is referenced by
10.1016/J.ORET.2018.08.009
Characteristics and Outcomes of Endogenous Endophthalmitis: Eight-Year Experience at a Tertiary Care Center.
Bobeck S. Modjtahedi (2019)
10.1186/s12886-020-01418-9
Endogenous Endophthalmitis: yield of the diagnostic evaluation
Kathleen A. Regan (2020)
10.4172/2476-2075.1000108
Endophthalmitis Prevention, Diagnostic Procedures and Treatment
Xhevat Lumi (2016)
10.1177/2474126418788498
Endogenous Endophthalmitis: Has the Opioid Crisis Impacted the Rates and Severity of Intravenous Drug-Related Cases?
Jonathan Foster Russell (2018)
10.1080/09273948.2016.1195000
Endogenous Endophthalmitis in the American and Korean Population: An 8-year Retrospective Study
Heeyoon Cho (2018)
10.1001/jamaophthalmol.2017.0650
An Outbreak of Endogenous Fungal Endophthalmitis Among Intravenous Drug Abusers in New England
Aubrey R Tirpack (2017)
10.1016/j.ophtha.2014.03.037
Retinal neovascularization and endogenous fungal endophthalmitis in intravenous drug users.
Thuy Doan (2014)
10.1016/J.ORET.2016.10.013
Intravenous Drug Use-Associated Endophthalmitis.
Bobeck S. Modjtahedi (2017)
10.1007/s12281-020-00392-5
Candida Infections in Immunocompetent Hosts: Pathogenesis and Diagnosis
Shivaprakash Mandya Rudramurthy (2020)
10.5812/SEMJ.74366
Age of Substance Use Onset in Kermanshah Province: Results from a Large Cross-Sectional Study
B. Hamzeh (2018)
10.1159/000485552
Intravenous Drug Use-Associated Scopulariopsis Endophthalmitis Treated with Systemic and Intravitreal Voriconazole
Joseph J Raevis (2018)
10.1007/978-3-319-29231-1_13
Endophthalmitis in Immunocompromised and Diabetic Patients
Yingna Liu (2016)
10.1007/s10792-018-0997-9
Ocular culture-proven endogenous endophthalmitis: a 5-year retrospective study of the microorganism spectrum at a tertiary referral center in Turkey
Hande Celiker (2018)
10.1080/09273948.2018.1465100
Endogenous Fungal Endophthalmitis Associated with Genitourinary Procedures
Boya Lei (2018)
10.1016/j.ajoc.2016.07.003
Iris abscess a rare presentation of intravenous drug abuse associated Candida endophthalmitis
J. Pierce (2016)
10.1080/09273948.2019.1705497
Does Endogenous Endophthalmitis Need a More Aggressive Treatment?
Sara Spelta (2020)
10.1159/000447120
Brown Heroin-Associated Candida albicans Ventriculitis and Endophthalmitis Treated with Voriconazole
Nora Elfiky (2016)
10.1038/srep28100
Risk factors for endophthalmitis requiring evisceration or enucleation
X. Lu (2016)
Semantic Scholar Logo Some data provided by SemanticScholar